Video Shorts

How Disparate PV Systems Stall Drug Launches

Could the US Reshore Generics?

Penny for Your Thoughts: Episode 16

Does TrumpRx's Rhetoric Match Actual Patient Savings?

Is TrumpRx Delivering Savings for Patients?

Can Data Prevent the Next Drug Shortage?

Penny for Your Thoughts: Episode 15

How Has Direct-to-Patient Played Out in H1?

Is Patient Affordability Better or Worse in 2026?

What the US Tariff Inquiry Into Germany Signals for pharma

Penny for Your Thoughts: Episode 14

Is Direct the Future of Commercialization?

How Patient Data from DTP Models Shape Commercial Decisions

What's Driving Direct-to-Patient Model Adoption Across Pharma?

What's Standing Between Reshoring Ambitions and Reality?

How Can Pharma Prepare for Potential USMCA Changes?

Could PBM Reform Actually Lower Net Drug Costs?

Why Aren't More Payers Using RWE?

Why Pharma Cost Trend Is Outpacing Overall Medical Trend

Penny for Your Thoughts: Episode 13

What Makes a Best-In-Class Field Reimbursement Team?

How Patient Services will Evolve in the Next 5 Years

What Pharma Looks for In a 3PL Partner in 2026

How 3PLs Have Evolved in Recent Years

Penny for Your Thoughts: Episode 12

How Will Specialty Launches Change as Cell and Gene Therapies Scale?

What Patient Support Will Look Like in 5 Years

How Supporting Adherence Boosts Patient Outcomes

Penny for Your Thoughts: Episode 11

Which US health policy will shape market access most?